Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the JAK2 V617F Mutation Detection Test is 7 days.

What are the prerequisites for the test JAK2 V617F Mutation Detection Test

  • There are no specific prerequisites for the JAK2 V617F Mutation Detection Test.
  • However, it is recommended that the test be ordered by a healthcare provider if there is suspicion of a myeloproliferative neoplasm (MPN) such as polycythemia vera, essential thrombocythemia, or primary myelofibrosis.
  • Prior to the test, the healthcare provider may perform a physical examination, review the patient's medical history, and order other blood tests to help confirm the need for the JAK2 V617F Mutation Detection Test.
  • It is important to follow any specific instructions provided by the healthcare provider or the laboratory conducting the test.

What are the measure values for the test JAK2 V617F Mutation Detection Test

  • Positive: Presence of JAK2 V617F mutation
  • Negative: Absence of JAK2 V617F mutation
  • Indeterminate: Inconclusive result, further testing may be required

What does this test JAK2 V617F Mutation Detection Test identify?

The JAK2 V617F Mutation Detection Test is a molecular test used to identify a specific mutation in the JAK2 gene. This mutation results in the substitution of a valine amino acid for a phenylalanine at position 617 in the JAK2 protein. The presence of this mutation is associated with various myeloproliferative neoplasms, including polycythemia vera, essential thrombocythemia, and primary myelofibrosis.

Why is this test JAK2 V617F Mutation Detection Test taken?

The JAK2 V617F Mutation Detection Test is taken to diagnose certain blood disorders, such as polycythemia vera, essential thrombocythemia, and primary myelofibrosis. This mutation is found in a high percentage of patients with these disorders, and the test helps to confirm the diagnosis and guide treatment decisions.

No FAQs available.

Customer Google Rating